Make us your home page
Instagram

The Daily Drivers: 2014 Mitsubishi Lancer GT

The Lancer has long been a mainstay in Mitsubishi's dwindling U.S. lineup, from its no-frills economy model to the coveted high-performance Evolution. Even with more than five years in its current body style, the 2014 Lancer remains one of the more attractive compact sedans on the road. We drove the GT, which slots just below the frisky Ralliart in the Lancer's five-trim lineup. (The Evo is a separate beast.)

Appearance: At a time when its compact competitors all appear to be undergoing redesigns, the Lancer may come off as a bit dated to some, but it's still a good-looking sedan. The Lancer sports the company's trapezoidal grille, which gives it an aggressive appearance. Sheet-metal creases in the hood and body panels, along with slender halogen headlights and eight-spoke 18-inch alloy wheels, complement this athletic look. The most dominant feature in the GT trim is a large rear wing that doesn't scream "performance" so much as "exaggerate."

Performance: The Lancer's 2.4-liter MIVEC 4-cylinder puts out 168 horsepower that makes for peppy acceleration, which is no doubt helped by the car's light weight (just over 3,000 pounds). Unfortunately, our tester was hamstrung by an optional continuously variable transmission, which contributes to cabin noise and anemic shifting. One detail we appreciate: large metallic paddle shifters that are mounted on the steering column. We wish more automakers — even some high-end ones — would follow this example. Still, we would go with the standard five-speed manual gearbox. The front-wheel-drive GT gets a sport-tuned suspension system that makes for taut cornering and a gripped, but not uncomfortable, ride. (If you want all-wheel drive, you'll have to opt for the SE or Ralliart trims.) The estimated MPG of 23/30 for the CVT falls short of some competitors.

Interior: The Lancer could benefit from more sound insulation as both road noise and the sound of the revvy CVT intrude on the cabin. Our tester's interior (lots of plastic) was black with faux metallic and gloss-black trim and on the drab side. Still, the Sport fabric seats were comfortable and supportive. The GT trim does come with some impressive (and welcome) standard features: auto-off headlights, LCD multi-information display, automatic AC control, rearview camera and keyless entry and start. The Lancer also has Mitsubishi's FUSE hands-free link System with USB port. The dash is anchored by a 6.1-inch touchscreen.

Our 3 favorites

Peter Couture

Steering wheel: Thick and leather-wrapped.

Sound: The 140-watt system has six speakers and is satellite-radio ready.

Price: A base Lancer with a manual transmission starts at $17,195.

Lyra Solochek

Camera: Rearview camera is a standard feature.

Trunk: 12.3 cubic feet of space. Not bad for a small sedan.

Controls: Simple, especially those AC dials.

The bottom line: The Mitsubishi Lancer GT, especially with a manual transmission, can add a little flair to your daily commute. Still, if you seek performance to match its sporty look, we'd opt for the Ralliart.









2014 Mitsubishi Lancer GT

Price: $17,195 base ES start; $21,445 GT start, $22,240 as tested

Powertrain:

2.4-liter MIVEC inline 4-cylinder, CVT (continuously variable transmission) with paddle shifters, FWD

Horsepower: 168 at 6,000 rpm

Torque: 167 pound-feet at 4,100 rpm

Curb weight: 3,032 pounds

Dimensions

in inches:

Wheelbase, 103.7

Length, 180

Width, 69.4

Height, 58.7

Seats: 5

Fuel economy:

23 miles per gallon city, 30 mpg highway

Fuel type:

regular unleaded

Safety features: Active Stability Control, seven airbags, 4-wheel disc brakes with ABS and electronic brake-force distribution, rearview camera

Website:

mitsubishicars.com/lancer

The Daily Drivers: 2014 Mitsubishi Lancer GT 10/24/13 [Last modified: Thursday, October 24, 2013 5:43pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...
  1. Massachusetts firm buys Tampa's Element apartment tower

    Real Estate

    TAMPA — Downtown Tampa's Element apartment tower sold this week to a Massachusetts-based real estate investment company that plans to upgrade the skyscraper's amenities and operate it long-term as a rental community.

    The Element apartment high-rise at 808 N Franklin St. in downtown Tampa has been sold to a Northland Investment Corp., a Massachusetts-based real estate investment company. JIM DAMASKE  |  Times
  2. New York town approves Legoland proposal

    News

    GOSHEN, N.Y. — New York is one step closer to a Lego dreamland. Goshen, a small town about fifty miles northwest of the Big Apple, has approved the site plan for a $500 million Legoland amusement park.

    A small New York town, Goshen approved the site plan for a $500 million Legoland amusement park. Legoland Florida is in Winter Haven. [Times file  photo]
  3. Jordan Park to get $20 million makeover and new senior housing

    Real Estate

    By WAVENEY ANN MOORE

    Times Staff Writer

    ST. PETERSBURG —The St. Petersburg Housing Authority, which bought back the troubled Jordan Park public housing complex this year, plans to spend about $20 million to improve the 237-unit property and construct a new three-story building for …

    Jordan Park, the historic public housing complex, is back in the hands of the St. Petersburg Housing Authority. The agency is working to improve the 237-unit complex. But the latest plan to build a new three-story building for seniors will mean 31 families have to find new homes. [LARA CERRI   |   Tampa Bay Times]
  4. Coming soon at two Tampa Bay area hospitals: a cancer treatment that could replace chemo

    Health

    A new cancer treatment that could eventually replace chemotherapy and bone marrow transplants — along with their debilitating side effects — soon will be offered at two of Tampa Bay's top-tier hospitals.

    Dr. Frederick Locke at Moffitt Cancer Center in Tampa is a principal investigator for an experimental therapy that retrains white blood cells in the body's immune system to fight cancer cells. The U.S. Food and Drug Administration approved these so-called "CAR-T" treatments for adults this month. In trials, 82 percent of cases responded well to the treatment, and 44 percent are still in remission at least eight months later, Locke said. [CHRIS URSO   |   Times]
  5. Regulator blasts Wells Fargo for deceptive auto insurance program

    Banking

    Wells Fargo engaged in unfair and deceptive practices, failed to properly manage risks and hasn't set aside enough money to pay back the customers it harmed, according to a confidential report by federal regulators.

    Wells Fargo engaged in unfair and deceptive practices, failed to properly manage risks and hasn't set aside enough money to pay back the customers it harmed, according to a confidential report by federal regulators.
[Photo by Spencer Platt/Getty Images, 2017]